Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma
Clinical trial NCT03116529 · TERMINATED
Trial details
- NCT number
- NCT03116529
- Sponsor
- University of Maryland, Baltimore
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-21
- Primary completion
- 2024-06-21
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.